Infections in the surgical setting: Epidemiology and effect of treatment with cefotaxime in a multicenter trial including 3,032 patients

Gaetano Privitera, Francesco Auxilia, Giuseppe Ortisi, Caterina Matinato, Silvana Castaldi, Antonio Pagano

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Hospital-acquired infections still represent a serious threat to the surgical patient. A nationwide survey of 259 Italian surgical wards involving 11,343 patients was conducted in October 1988. Hospital-acquired infections were recorded in 565 (5%) patients: the microorganisms most commonly involved were gram-negative rods (60% of all isolates), 41% of the infected patients presented one or more intrinsic predisposing factor, and 65% had undergone some invasive procedure. The studied group represented 23% of all surgical patients in the country on the days of the survey. Following the epidemiologic survey, an open multicenter study was conducted in the same wards to evaluate the efficacy and tolerability of cefotaxime (1 g, 2 or 3 times per day) in the treatment of nosocomial surgical infections. Among 3,032 evaluable patients, 1,295 intra-abdominal, 610 wound and soft tissue, 554 urinary, and 367 respiratory infections were observed. Treatment was judged to be clinically effective in 94% of patients, and side effects, mostly involving the gastrointestinal tract, were observed in 1.4% of patients; but interruption of the treatment was required only in 19 patients (0.6%). This study confirms that cefotaxime, after over a decade of use, retains high efficacy in the treatment for nosocomial infections and induces a low rate of side effects.

Original languageEnglish
JournalAmerican Journal of Surgery
Volume164
Issue number4 SUPPL.
DOIs
Publication statusPublished - 1992

Fingerprint

Cefotaxime
Multicenter Studies
Epidemiology
Infection
Cross Infection
Therapeutics
Intrinsic Factor
Respiratory Tract Infections
Causality
Gastrointestinal Tract
Wounds and Injuries

ASJC Scopus subject areas

  • Surgery

Cite this

Infections in the surgical setting : Epidemiology and effect of treatment with cefotaxime in a multicenter trial including 3,032 patients. / Privitera, Gaetano; Auxilia, Francesco; Ortisi, Giuseppe; Matinato, Caterina; Castaldi, Silvana; Pagano, Antonio.

In: American Journal of Surgery, Vol. 164, No. 4 SUPPL., 1992.

Research output: Contribution to journalArticle

Privitera, Gaetano ; Auxilia, Francesco ; Ortisi, Giuseppe ; Matinato, Caterina ; Castaldi, Silvana ; Pagano, Antonio. / Infections in the surgical setting : Epidemiology and effect of treatment with cefotaxime in a multicenter trial including 3,032 patients. In: American Journal of Surgery. 1992 ; Vol. 164, No. 4 SUPPL.
@article{d4d5903e2aaa456a81e97cf171cd3b24,
title = "Infections in the surgical setting: Epidemiology and effect of treatment with cefotaxime in a multicenter trial including 3,032 patients",
abstract = "Hospital-acquired infections still represent a serious threat to the surgical patient. A nationwide survey of 259 Italian surgical wards involving 11,343 patients was conducted in October 1988. Hospital-acquired infections were recorded in 565 (5{\%}) patients: the microorganisms most commonly involved were gram-negative rods (60{\%} of all isolates), 41{\%} of the infected patients presented one or more intrinsic predisposing factor, and 65{\%} had undergone some invasive procedure. The studied group represented 23{\%} of all surgical patients in the country on the days of the survey. Following the epidemiologic survey, an open multicenter study was conducted in the same wards to evaluate the efficacy and tolerability of cefotaxime (1 g, 2 or 3 times per day) in the treatment of nosocomial surgical infections. Among 3,032 evaluable patients, 1,295 intra-abdominal, 610 wound and soft tissue, 554 urinary, and 367 respiratory infections were observed. Treatment was judged to be clinically effective in 94{\%} of patients, and side effects, mostly involving the gastrointestinal tract, were observed in 1.4{\%} of patients; but interruption of the treatment was required only in 19 patients (0.6{\%}). This study confirms that cefotaxime, after over a decade of use, retains high efficacy in the treatment for nosocomial infections and induces a low rate of side effects.",
author = "Gaetano Privitera and Francesco Auxilia and Giuseppe Ortisi and Caterina Matinato and Silvana Castaldi and Antonio Pagano",
year = "1992",
doi = "10.1016/S0002-9610(06)80050-4",
language = "English",
volume = "164",
journal = "American Journal of Surgery",
issn = "0002-9610",
publisher = "Elsevier Inc.",
number = "4 SUPPL.",

}

TY - JOUR

T1 - Infections in the surgical setting

T2 - Epidemiology and effect of treatment with cefotaxime in a multicenter trial including 3,032 patients

AU - Privitera, Gaetano

AU - Auxilia, Francesco

AU - Ortisi, Giuseppe

AU - Matinato, Caterina

AU - Castaldi, Silvana

AU - Pagano, Antonio

PY - 1992

Y1 - 1992

N2 - Hospital-acquired infections still represent a serious threat to the surgical patient. A nationwide survey of 259 Italian surgical wards involving 11,343 patients was conducted in October 1988. Hospital-acquired infections were recorded in 565 (5%) patients: the microorganisms most commonly involved were gram-negative rods (60% of all isolates), 41% of the infected patients presented one or more intrinsic predisposing factor, and 65% had undergone some invasive procedure. The studied group represented 23% of all surgical patients in the country on the days of the survey. Following the epidemiologic survey, an open multicenter study was conducted in the same wards to evaluate the efficacy and tolerability of cefotaxime (1 g, 2 or 3 times per day) in the treatment of nosocomial surgical infections. Among 3,032 evaluable patients, 1,295 intra-abdominal, 610 wound and soft tissue, 554 urinary, and 367 respiratory infections were observed. Treatment was judged to be clinically effective in 94% of patients, and side effects, mostly involving the gastrointestinal tract, were observed in 1.4% of patients; but interruption of the treatment was required only in 19 patients (0.6%). This study confirms that cefotaxime, after over a decade of use, retains high efficacy in the treatment for nosocomial infections and induces a low rate of side effects.

AB - Hospital-acquired infections still represent a serious threat to the surgical patient. A nationwide survey of 259 Italian surgical wards involving 11,343 patients was conducted in October 1988. Hospital-acquired infections were recorded in 565 (5%) patients: the microorganisms most commonly involved were gram-negative rods (60% of all isolates), 41% of the infected patients presented one or more intrinsic predisposing factor, and 65% had undergone some invasive procedure. The studied group represented 23% of all surgical patients in the country on the days of the survey. Following the epidemiologic survey, an open multicenter study was conducted in the same wards to evaluate the efficacy and tolerability of cefotaxime (1 g, 2 or 3 times per day) in the treatment of nosocomial surgical infections. Among 3,032 evaluable patients, 1,295 intra-abdominal, 610 wound and soft tissue, 554 urinary, and 367 respiratory infections were observed. Treatment was judged to be clinically effective in 94% of patients, and side effects, mostly involving the gastrointestinal tract, were observed in 1.4% of patients; but interruption of the treatment was required only in 19 patients (0.6%). This study confirms that cefotaxime, after over a decade of use, retains high efficacy in the treatment for nosocomial infections and induces a low rate of side effects.

UR - http://www.scopus.com/inward/record.url?scp=0026941457&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026941457&partnerID=8YFLogxK

U2 - 10.1016/S0002-9610(06)80050-4

DO - 10.1016/S0002-9610(06)80050-4

M3 - Article

C2 - 1443361

AN - SCOPUS:0026941457

VL - 164

JO - American Journal of Surgery

JF - American Journal of Surgery

SN - 0002-9610

IS - 4 SUPPL.

ER -